Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 12:06 AM
Ignite Modification Date: 2025-12-25 @ 12:06 AM
NCT ID: NCT06699758
Eligibility Criteria: Inclusion Criteria: * Female subjects between 18 - 55 years of age. * Participants are willing and able to comply with all scheduled visits, treatment plan, laboratory tests, lifestyle considerations, and other study procedures. * Patients with the ability to comprehend and sign the informed consent. * Written informed consent obtained prior to any screening procedures. * Subjects in good health with no baseline disease of any kind. Exclusion Criteria: * Participants are not willing or able to comply with either: all scheduled visits, treatment plan, laboratory tests, lifestyle considerations, or other study procedures. * Participants who are currently under medical follow-up for any medical condition or who are regularly taking medication for any condition. * Subject has experienced symptoms consistent with a respiratory infection within the 7 days prior to the administration of the investigational treatment. * Have a known history of human immunodeficiency virus infection, Hepatitis B or Hepatitis C; testing is not required in the absence of prior documentation or known history. * Have a known history of drug substance abuse. * Pregnant or breastfeeding women, where pregnancy is defined as the state of a female after conception and until the termination of gestation. * Any other condition that, in the opinion if the Investigator, may interfere with the efficacy and/or safety evaluation of the trial. * Any condition or situation precluding or interfering with the compliance with the protocol. * Participant is currently enrolled or has enrolled in a clinical trial three months prior to inclusion in the current study.
Healthy Volunteers: True
Sex: FEMALE
Minimum Age: 18 Years
Maximum Age: 55 Years
Study: NCT06699758
Study Brief:
Protocol Section: NCT06699758